ArticleJournal of gastrointestinal oncology2026
Development and validation of a model for predicting short-term complications after hepatectomy in patients with primary liver cancer.
Article in Journal of gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Currently, surgical resection remains the preferred treatment for primary liver cancer. Nevertheless, the incidence of postoperative complications remains considerable. This study sought to develop and validate a model for predicting short-term postoperative complications in patients undergoing hepatectomy for primary liver cancer in order to provide a reference for perioperative management strategies. Methods: A retrospective analysis was conducted on patients with primary liver cancer who underwent hepatectomy in Nantong First People's Hospital from January 2015 to October 2024. Participants were randomly assigned to a training set and a validation set at a 7:3 ratio, and baseline variables were compared. Potential predictors were screened via least absolute shrinkage and selection operator (LASSO) regression analysis within the training set. Subsequently, multivariate logistic regression was employed to identify the independent predictive factors of postoperative complications, which were then incorporated into a predictive nomogram. The performance of the model was evaluated according to receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA) in both the training and validation sets. Results: A total of 397 patients were included in the study, of whom 136 (34.26%) experienced complications within 30 days after hepatectomy. Four variables emerged as significant predictive factors: operative time [odds ratio (OR) =1.01; 95% confidence interval (CI): 1.00-1.01; P=0.003], lowest intraoperative heart rate (HR) (OR =1.17; 95% CI: 1.12-1.23; P<0.001), lowest intraoperative mean arterial pressure (MAP) (OR =0.93; 95% CI: 0.89-0.97; P=0.001), and prognostic nutritional index (PNI) (OR =0.92; 95% CI: 0.86-0.98; P=0.02). The nomogram constructed with the above four parameters demonstrated robust predictive accuracy, with area under the ROC curve (AUC) values of 0.870 (95% CI: 0.824-0.916) in the training set and 0.874 (95% CI: 0.809-0.939) in the validation set. Calibration curves indicated strong agreement between the predicted and observed outcomes in both sets. DCA confirmed the clinical utility of the nomogram across datasets. Conclusions: The model we developed could effectively predict short-term complications in patients with primary liver cancer after hepatectomy and was based on four parameters: operation time, lowest intraoperative MAP, lowest intraoperative HR, and PNI. This tool offers valuable support for risk stratification and clinical decision-making in perioperative management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.